nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—Distention—Metformin—polycystic ovary syndrome	0.189	0.199	CcSEcCtD
Palonosetron—Pain in extremity—Metformin—polycystic ovary syndrome	0.0323	0.034	CcSEcCtD
Palonosetron—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.0295	0.0311	CcSEcCtD
Palonosetron—Abdominal distension—Metformin—polycystic ovary syndrome	0.0281	0.0296	CcSEcCtD
Palonosetron—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.0236	0.0248	CcSEcCtD
Palonosetron—Bradycardia—Metformin—polycystic ovary syndrome	0.0228	0.024	CcSEcCtD
Palonosetron—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.022	0.0231	CcSEcCtD
Palonosetron—Eye disorder—Metformin—polycystic ovary syndrome	0.0209	0.022	CcSEcCtD
Palonosetron—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0208	0.0218	CcSEcCtD
Palonosetron—Angiopathy—Metformin—polycystic ovary syndrome	0.0203	0.0214	CcSEcCtD
Palonosetron—Immune system disorder—Metformin—polycystic ovary syndrome	0.0202	0.0213	CcSEcCtD
Palonosetron—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0202	0.0212	CcSEcCtD
Palonosetron—Chills—Metformin—polycystic ovary syndrome	0.0201	0.0211	CcSEcCtD
Palonosetron—Malnutrition—Metformin—polycystic ovary syndrome	0.0195	0.0205	CcSEcCtD
Palonosetron—Erythema—Metformin—polycystic ovary syndrome	0.0195	0.0205	CcSEcCtD
Palonosetron—Flatulence—Metformin—polycystic ovary syndrome	0.0192	0.0202	CcSEcCtD
Palonosetron—Dysgeusia—Metformin—polycystic ovary syndrome	0.0191	0.0201	CcSEcCtD
Palonosetron—Hypertension—Metformin—polycystic ovary syndrome	0.0168	0.0177	CcSEcCtD
Palonosetron—Myalgia—Metformin—polycystic ovary syndrome	0.0166	0.0174	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0165	0.0173	CcSEcCtD
Palonosetron—Discomfort—Metformin—polycystic ovary syndrome	0.0164	0.0172	CcSEcCtD
Palonosetron—Infection—Metformin—polycystic ovary syndrome	0.0158	0.0166	CcSEcCtD
Palonosetron—Shock—Metformin—polycystic ovary syndrome	0.0156	0.0164	CcSEcCtD
Palonosetron—Nervous system disorder—Metformin—polycystic ovary syndrome	0.0156	0.0164	CcSEcCtD
Palonosetron—Skin disorder—Metformin—polycystic ovary syndrome	0.0154	0.0162	CcSEcCtD
Palonosetron—Anorexia—Metformin—polycystic ovary syndrome	0.0151	0.0159	CcSEcCtD
Palonosetron—Hypotension—Metformin—polycystic ovary syndrome	0.0148	0.0156	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0145	0.0152	CcSEcCtD
Palonosetron—Paraesthesia—Metformin—polycystic ovary syndrome	0.0143	0.015	CcSEcCtD
Palonosetron—Dyspnoea—Metformin—polycystic ovary syndrome	0.0142	0.0149	CcSEcCtD
Palonosetron—Somnolence—Metformin—polycystic ovary syndrome	0.0141	0.0149	CcSEcCtD
Palonosetron—Dyspepsia—Metformin—polycystic ovary syndrome	0.014	0.0147	CcSEcCtD
Palonosetron—Decreased appetite—Metformin—polycystic ovary syndrome	0.0138	0.0145	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.0137	0.0144	CcSEcCtD
Palonosetron—Fatigue—Metformin—polycystic ovary syndrome	0.0137	0.0144	CcSEcCtD
Palonosetron—Constipation—Metformin—polycystic ovary syndrome	0.0136	0.0143	CcSEcCtD
Palonosetron—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.013	0.0137	CcSEcCtD
Palonosetron—Abdominal pain—Metformin—polycystic ovary syndrome	0.0126	0.0132	CcSEcCtD
Palonosetron—Asthenia—Metformin—polycystic ovary syndrome	0.0114	0.012	CcSEcCtD
Palonosetron—Pruritus—Metformin—polycystic ovary syndrome	0.0112	0.0118	CcSEcCtD
Palonosetron—Diarrhoea—Metformin—polycystic ovary syndrome	0.0109	0.0114	CcSEcCtD
Palonosetron—Dizziness—Metformin—polycystic ovary syndrome	0.0105	0.0111	CcSEcCtD
Palonosetron—Vomiting—Metformin—polycystic ovary syndrome	0.0101	0.0106	CcSEcCtD
Palonosetron—Rash—Metformin—polycystic ovary syndrome	0.01	0.0105	CcSEcCtD
Palonosetron—Dermatitis—Metformin—polycystic ovary syndrome	0.01	0.0105	CcSEcCtD
Palonosetron—Headache—Metformin—polycystic ovary syndrome	0.00996	0.0105	CcSEcCtD
Palonosetron—Nausea—Metformin—polycystic ovary syndrome	0.00944	0.00993	CcSEcCtD
Palonosetron—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.00135	0.0272	CbGpPWpGaD
Palonosetron—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.00104	0.021	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000974	0.0197	CbGpPWpGaD
Palonosetron—CYP2D6—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000962	0.0195	CbGpPWpGaD
Palonosetron—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.000927	0.0187	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000889	0.018	CbGpPWpGaD
Palonosetron—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.000843	0.0171	CbGpPWpGaD
Palonosetron—CYP1A2—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000815	0.0165	CbGpPWpGaD
Palonosetron—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000745	0.0151	CbGpPWpGaD
Palonosetron—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.000681	0.0138	CbGpPWpGaD
Palonosetron—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.000651	0.0132	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000633	0.0128	CbGpPWpGaD
Palonosetron—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000629	0.0127	CbGpPWpGaD
Palonosetron—CYP1A2—Estrogen Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000628	0.0127	CbGpPWpGaD
Palonosetron—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000628	0.0127	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000619	0.0125	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000573	0.0116	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000551	0.0111	CbGpPWpGaD
Palonosetron—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000532	0.0108	CbGpPWpGaD
Palonosetron—CYP2D6—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000525	0.0106	CbGpPWpGaD
Palonosetron—CYP2D6—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000505	0.0102	CbGpPWpGaD
Palonosetron—CYP1A2—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000484	0.0098	CbGpPWpGaD
Palonosetron—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000449	0.00908	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—polycystic ovary syndrome	0.000447	0.00903	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000445	0.00901	CbGpPWpGaD
Palonosetron—CYP1A2—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000445	0.009	CbGpPWpGaD
Palonosetron—CYP1A2—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000428	0.00866	CbGpPWpGaD
Palonosetron—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000411	0.00831	CbGpPWpGaD
Palonosetron—CYP2D6—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.00039	0.0079	CbGpPWpGaD
Palonosetron—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000374	0.00756	CbGpPWpGaD
Palonosetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000368	0.00744	CbGpPWpGaD
Palonosetron—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000363	0.00734	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000345	0.00697	CbGpPWpGaD
Palonosetron—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000344	0.00695	CbGpPWpGaD
Palonosetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000342	0.00692	CbGpPWpGaD
Palonosetron—CYP1A2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000341	0.00689	CbGpPWpGaD
Palonosetron—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000338	0.00683	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.000331	0.00669	CbGpPWpGaD
Palonosetron—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00033	0.00668	CbGpPWpGaD
Palonosetron—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000317	0.00642	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000312	0.0063	CbGpPWpGaD
Palonosetron—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000308	0.00622	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000298	0.00603	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000292	0.0059	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00029	0.00586	CbGpPWpGaD
Palonosetron—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000286	0.00578	CbGpPWpGaD
Palonosetron—CYP1A2—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000284	0.00574	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000277	0.00561	CbGpPWpGaD
Palonosetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000271	0.00548	CbGpPWpGaD
Palonosetron—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000267	0.0054	CbGpPWpGaD
Palonosetron—CYP1A2—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.000259	0.00524	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000253	0.00511	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000241	0.00487	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000239	0.00484	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000237	0.0048	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.000235	0.00475	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000235	0.00475	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000229	0.00464	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000229	0.00462	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.000229	0.00462	CbGpPWpGaD
Palonosetron—CYP1A2—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000229	0.00462	CbGpPWpGaD
Palonosetron—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000226	0.00458	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000225	0.00456	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000224	0.00452	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000222	0.0045	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000221	0.00446	CbGpPWpGaD
Palonosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00022	0.00445	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000219	0.00444	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000219	0.00443	CbGpPWpGaD
Palonosetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000218	0.00441	CbGpPWpGaD
Palonosetron—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000215	0.00436	CbGpPWpGaD
Palonosetron—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000214	0.00433	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000214	0.00432	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000203	0.00411	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000195	0.00394	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000192	0.00388	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000186	0.00376	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000185	0.00374	CbGpPWpGaD
Palonosetron—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000182	0.00369	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000181	0.00367	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000179	0.00362	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000177	0.00358	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000177	0.00358	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000176	0.00357	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000176	0.00357	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000175	0.00353	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000171	0.00345	CbGpPWpGaD
Palonosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00017	0.00344	CbGpPWpGaD
Palonosetron—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000163	0.00329	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000162	0.00328	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000158	0.0032	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000156	0.00316	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000152	0.00306	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00015	0.00303	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000149	0.00302	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000148	0.00299	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000148	0.00298	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000147	0.00298	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000145	0.00294	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000144	0.00291	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000143	0.0029	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000143	0.00289	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000141	0.00285	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000138	0.00279	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000134	0.00271	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000132	0.00268	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000132	0.00267	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000125	0.00253	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000125	0.00253	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000125	0.00252	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000123	0.00249	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000117	0.00237	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000117	0.00236	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000116	0.00234	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000115	0.00233	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000115	0.00233	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000114	0.0023	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000114	0.0023	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000112	0.00226	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000107	0.00217	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000106	0.00215	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000104	0.0021	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000102	0.00207	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	9.87e-05	0.002	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	9.74e-05	0.00197	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	9.65e-05	0.00195	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	9.63e-05	0.00195	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	9.53e-05	0.00193	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	9.5e-05	0.00192	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	9.4e-05	0.0019	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	9.27e-05	0.00187	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	9.03e-05	0.00183	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	8.62e-05	0.00174	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	8.61e-05	0.00174	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	8.26e-05	0.00167	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	7.96e-05	0.00161	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	7.85e-05	0.00159	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	7.62e-05	0.00154	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	7.56e-05	0.00153	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	7.56e-05	0.00153	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	7.52e-05	0.00152	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	7.32e-05	0.00148	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	7.03e-05	0.00142	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	7.01e-05	0.00142	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	7e-05	0.00142	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	6.68e-05	0.00135	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	6.53e-05	0.00132	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	6.4e-05	0.0013	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	6.4e-05	0.0013	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	6.32e-05	0.00128	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	6.14e-05	0.00124	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	6.06e-05	0.00123	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	5.98e-05	0.00121	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	5.98e-05	0.00121	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	5.95e-05	0.0012	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	5.93e-05	0.0012	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	5.82e-05	0.00118	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	5.43e-05	0.0011	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	5.4e-05	0.00109	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	5.15e-05	0.00104	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	5.06e-05	0.00102	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	5.06e-05	0.00102	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	5.01e-05	0.00101	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	4.94e-05	0.001	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	4.94e-05	0.001	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	4.87e-05	0.000984	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	4.79e-05	0.000969	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	4.75e-05	0.00096	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	4.59e-05	0.000929	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	4.58e-05	0.000926	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	4.53e-05	0.000916	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	4.24e-05	0.000858	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	4.04e-05	0.000816	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	4.02e-05	0.000813	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	3.91e-05	0.00079	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	3.91e-05	0.00079	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	3.85e-05	0.000779	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	3.84e-05	0.000776	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.79e-05	0.000767	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	3.51e-05	0.00071	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	3.43e-05	0.000694	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	3.42e-05	0.000692	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	3.32e-05	0.000672	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	3.27e-05	0.000662	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	3.26e-05	0.00066	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.22e-05	0.000652	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	3.1e-05	0.000628	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	3.06e-05	0.000619	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.06e-05	0.000618	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	2.97e-05	0.000602	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	2.96e-05	0.000599	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.96e-05	0.000599	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	2.91e-05	0.000588	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	2.86e-05	0.000578	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	2.82e-05	0.00057	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	2.74e-05	0.000555	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	2.71e-05	0.000548	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	2.64e-05	0.000534	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	2.59e-05	0.000524	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	2.56e-05	0.000518	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	2.52e-05	0.000509	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	2.52e-05	0.000509	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	2.51e-05	0.000508	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	2.42e-05	0.000489	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	2.32e-05	0.00047	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.31e-05	0.000467	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	2.3e-05	0.000464	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	2.3e-05	0.000464	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.28e-05	0.000461	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	2.24e-05	0.000454	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—TH—polycystic ovary syndrome	2.18e-05	0.000441	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	2.17e-05	0.00044	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	2.17e-05	0.000438	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	2.13e-05	0.000432	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	2.12e-05	0.000429	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	2e-05	0.000405	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.99e-05	0.000403	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.94e-05	0.000392	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.87e-05	0.000378	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.85e-05	0.000373	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.8e-05	0.000363	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.79e-05	0.000363	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.78e-05	0.00036	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.77e-05	0.000358	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.7e-05	0.000343	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.69e-05	0.000342	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.67e-05	0.000338	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.65e-05	0.000333	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	1.61e-05	0.000325	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	1.51e-05	0.000305	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	1.5e-05	0.000303	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.44e-05	0.00029	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.43e-05	0.000288	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.39e-05	0.00028	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.36e-05	0.000275	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.3e-05	0.000264	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.27e-05	0.000257	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.21e-05	0.000246	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.2e-05	0.000242	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.19e-05	0.000241	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.16e-05	0.000235	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.11e-05	0.000224	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.05e-05	0.000212	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.03e-05	0.000208	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.01e-05	0.000205	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.01e-05	0.000204	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	9.79e-06	0.000198	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	7.94e-06	0.000161	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	7.83e-06	0.000158	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—INS—polycystic ovary syndrome	7.79e-06	0.000158	CbGpPWpGaD
